Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder

Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor. Duloxetine-induced liver injury in patients with preexisting liver disease or chronic alcohol use is known. However, we have found that duloxetine can also induce liver injury in cases without those risk factors. We recommend that...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Seung-Gul, Park, Young-Min, Lee, Heon-Jeong, Yoon, Byungmun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182394/
https://www.ncbi.nlm.nih.gov/pubmed/21994516
http://dx.doi.org/10.4306/pi.2011.8.3.269
_version_ 1782212910299217920
author Kang, Seung-Gul
Park, Young-Min
Lee, Heon-Jeong
Yoon, Byungmun
author_facet Kang, Seung-Gul
Park, Young-Min
Lee, Heon-Jeong
Yoon, Byungmun
author_sort Kang, Seung-Gul
collection PubMed
description Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor. Duloxetine-induced liver injury in patients with preexisting liver disease or chronic alcohol use is known. However, we have found that duloxetine can also induce liver injury in cases without those risk factors. We recommend that clinicians should monitor liver function carefully following duloxetine treatment.
format Online
Article
Text
id pubmed-3182394
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Neuropsychiatric Association
record_format MEDLINE/PubMed
spelling pubmed-31823942011-10-12 Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder Kang, Seung-Gul Park, Young-Min Lee, Heon-Jeong Yoon, Byungmun Psychiatry Investig Case Report Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor. Duloxetine-induced liver injury in patients with preexisting liver disease or chronic alcohol use is known. However, we have found that duloxetine can also induce liver injury in cases without those risk factors. We recommend that clinicians should monitor liver function carefully following duloxetine treatment. Korean Neuropsychiatric Association 2011-09 2011-08-10 /pmc/articles/PMC3182394/ /pubmed/21994516 http://dx.doi.org/10.4306/pi.2011.8.3.269 Text en Copyright © 2011 Korean Neuropsychiatric Association http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kang, Seung-Gul
Park, Young-Min
Lee, Heon-Jeong
Yoon, Byungmun
Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
title Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
title_full Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
title_fullStr Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
title_full_unstemmed Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
title_short Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
title_sort duloxetine-induced liver injury in patients with major depressive disorder
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182394/
https://www.ncbi.nlm.nih.gov/pubmed/21994516
http://dx.doi.org/10.4306/pi.2011.8.3.269
work_keys_str_mv AT kangseunggul duloxetineinducedliverinjuryinpatientswithmajordepressivedisorder
AT parkyoungmin duloxetineinducedliverinjuryinpatientswithmajordepressivedisorder
AT leeheonjeong duloxetineinducedliverinjuryinpatientswithmajordepressivedisorder
AT yoonbyungmun duloxetineinducedliverinjuryinpatientswithmajordepressivedisorder

Ejemplares similares